S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6988 −0.08%
PRE-MKT · 04:20 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 29The week ahead

Nov 18, 2026

  1. stake
    222 Capital, U/I dated March 25, 2003 disclosed a stake of 9.7% in FF

    Schedule 13D filed with the SEC; the filer's stated purpose is on the stock's holders page.

  2. event
    ALDX filed an 8-K: Delisting notice

    Aldeyra Therapeutics, Inc. reported item 3.01 (Delisting notice) to the SEC on 2026-11-17.

  3. event
    ITGR filed an 8-K: Delisting notice

    Integer Holdings Corp reported item 3.01 (Delisting notice) to the SEC on 2026-11-17.

  4. Congress
    Sen. John Boozman sold CMBS ($1K–$15K)

    Disclosed under the STOCK Act, 27 days after the trade.

  5. Congress
    Sen. John Boozman sold TLH ($1K–$15K)

    Disclosed under the STOCK Act, 27 days after the trade.

  6. Insider buy
    10% owner bought $411K of KTTA

    10% owner at Pasithea Therapeutics Corp. filed an open-market buy worth $411K.

  7. 13F
    13F season: 4 tracked funds now show 2026-09-30 holdings, 137 brand-new positions

    Quarterly 13F filings for 2026-09-30 landed across our tracked fund roster.

See today’s digest and the full archive